Designing Dual Inhibitors: Tricyclic Compounds Target AChE/MAO-B
Recent research in the field of medicinal chemistry has unveiled an exciting prospect in the development of novel therapeutic agents ...
Tag: neurodegenerative disease therapies
Revolutionizing Parkinson’s Treatment with PLGA Carriers
It looks like your text got cut off at the end — you were describing the dopamine-loaded albumin/PLGA nanoparticles (DA-PLGA) ...
Selecting Amlenetug: Targeting α-Synucleinopathies Rationally
In the relentless pursuit of therapies to combat neurodegenerative diseases, a transformative breakthrough has emerged with the rational design and ...
Alzheimer’s Drug Demonstrates Good Tolerability Beyond Clinical Trials
In 2023, the Food and Drug Administration (FDA) rendered a groundbreaking decision by approving lecanemab, a novel therapeutic agent aimed ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!